In vitro percutaneous absorption of genistein from topical gels through human skin

References

• Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. (2005). Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm, 289:167–178.
   PubMed Web of Science ®Google Scholar
• Al-Khalili M, Meidan VM, Michniak BB. (2003). Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS Pharmsci, 5:E14.
   PubMedGoogle Scholar
• Aqil M, Ahad A, Sultana Y, Ali A. (2007). Status of terpenes as skin penetration enhancers. Drug Discov Today, 12:1061–1067.
   PubMed Web of Science ®Google Scholar
• Asbill CS, El-Kattan AF, Michniak B. (2000). Enhancement of transdermal drug delivery: chemical and physical approaches. Crit Rev Ther Drug Carrier Syst, 17:621–658.
   PubMed Web of Science ®Google Scholar
• Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F. (2007). Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol, 61:276–285.
   PubMedGoogle Scholar
• Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ et al. (2002). Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr, 75:126–136.
   PubMed Web of Science ®Google Scholar
• Cave NJ, Backus RC, Marks SL, Klasing KC. (2007). The bioavailability and disposition kinetics of genistein in cats. J Vet Pharmacol Ther, 30:327–335.
   PubMed Web of Science ®Google Scholar
• Chang JS, Tsai YH, Wu PC, Huang YB. (2007). The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel. Drug Dev Ind Pharm, 33:984–989.
   PubMed Web of Science ®Google Scholar
• Cornwell, P.A., Barry, B.W., Bouwstra, J.A., Gooris, G.S. (1996). Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small angle x-ray diffraction and enhancer uptake studies. Int. J. Pharm. 127: 9–26.
   Web of Science ®Google Scholar
• Degim IT, Acartürk F, Erdogan D, Demirez Lortlar N. (2003). Transdermal administration of bromocriptine. Biol Pharm Bull, 26:501–505.
   PubMed Web of Science ®Google Scholar
• El-Kattan AF, Asbill CS, Kim N, Michniak BB. (2000). Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. Drug Deliv, 7:147–153.
   PubMed Web of Science ®Google Scholar
• Godwin DA, Michniak BB. (1999). Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm, 25:905–915.
   PubMed Web of Science ®Google Scholar
• Hawrylewicz EJ, Zapata JJ, Blair WH. (1995). Soy and experimental cancer: animal studies. J Nutr, 125:698S–708S.
   PubMed Web of Science ®Google Scholar
• Huang ZR, Hung CF, Lin YK, Fang JY. (2008). In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm, 364:36–44.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thomas NS, Panchagnula R. (2002). Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release, 79:93–101.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, Hamishehkar H, Nokhodchi A. (2009). Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol (In Press).
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM. (2010). Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target (In Press).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics, 2008. CA Cancer J Clin, 58:71–96.
   PubMed Web of Science ®Google Scholar
• Khan N, Afaq F, Mukhtar H. (2008). Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal, 10:475–510.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana V, Bhaskar P. (2002). Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm, 247:91–102.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Kumar MS, Raju V, Lakshmi M, Rama B. (2008). Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis. Drug Deliv, 15:227–234.
   PubMed Web of Science ®Google Scholar
• Liu H, Li S, Wang Y, Yao H, Zhang Y. (2006). Effect of vehicles and enhancers on the topical delivery of cyclosporin A. Int J Pharm, 311:182–186.
   PubMed Web of Science ®Google Scholar
• Mallis LM, Sarkahian AB, Harris HA, Zhang MY, McConnell OJ. (2003). Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 796:71–86.
   PubMed Web of Science ®Google Scholar
• Minghetti P, Cilurzo F, Casiraghi A, Montanari L. (2006). Evaluation of ex vivo human skin permeation of genistein and daidzein. Drug Deliv, 13:411–415.
   PubMed Web of Science ®Google Scholar
• Minghetti P, Casiraghi A, Cilurzo F, Tosi L, Montanari L, Trespidi L. (2003). Formulation study and anti-inflammatory efficacy of topical semi-solids containing a nitro ester of flurbiprofen. Skin Pharmacol Appl Skin Physiol, 16:91–99.
   PubMedGoogle Scholar
• Narishetty ST, Panchagnula R. (2005). Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release, 102:59–70.
   PubMed Web of Science ®Google Scholar
• Nielsen IL, Williamson G. (2007). Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer, 57:1–10.
   PubMed Web of Science ®Google Scholar
• Okabe H, Obata Y, Takayama K, Nagai T. (1990). Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des Deliv, 6:229–238.
   PubMedGoogle Scholar
• Padula C, Pappani A, Santi P. (2008). In vitro permeation of levothyroxine across the skin. Int J Pharm, 349:161–165.
   PubMedGoogle Scholar
• Persky V, Van Horn L. (1995). Epidemiology of soy and cancer: perspectives and directions. J Nutr, 125:709S–712S.
   PubMed Web of Science ®Google Scholar
• Puglia C, Bonina F, Trapani G, Franco M, Ricci M. (2001). Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations. Int J Pharm, 228:79–87.
   PubMed Web of Science ®Google Scholar
• Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G, Cassidy A. (2003). Bioavailability of phyto-oestrogens. Br J Nutr, 89 Suppl 1:S45–S58.
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Panchagnula R, Stemmer K, Ashraf M. (1991). Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol, 4:235–245.
   PubMedGoogle Scholar
• Ritschel WA, Ye W, Buhse L, Reepmeyer JC. (2008). Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use. Int J Pharm, 362:67–73.
   PubMedGoogle Scholar
• Sapra B, Jain S, Tiwary AK. (2008). Percutaneous permeation enhancement by terpenes: mechanistic view. Aaps J, 10:120–132.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT et al. (2001). Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr, 131:1362S–1375S.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS et al. (2003). Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr, 133:1027–1035.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, Wolfe BE et al. (2003). Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr, 77:411–419.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brzezinski A, Brown NM, Desai PB, Melhem M, Meredith T et al. (2005). Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women. J Agric Food Chem, 53:1938–1944.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharmscitech, 8:E104.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 26:1131–1140.
   PubMed Web of Science ®Google Scholar
• Wei H, Bowen R, Zhang X, Lebwohl M. (1998). Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis, 19:1509–1514.
   PubMed Web of Science ®Google Scholar
• Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. (1995). Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr, 125:2307–2315.
   PubMed Web of Science ®Google Scholar
• Zubik L, Meydani M. (2003). Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr, 77:1459–1465.
   PubMed Web of Science ®Google Scholar